APPLICATION
BLA761468
TYPE
BLA
ORIGINAL APPROVAL
2026-05-22
LATEST ACTION
2026-05-22
ROUTE
SUBCUTANEOUS, POWDER,FOR SOLUTION
DOSAGE FORM
INJECTION
MARKETING STATUS
Prescription
Products
HEPCLUDEXPrescription
BULEVIRTIDE-GMOD 8.5MG · INJECTION · POWDER,FOR SOLUTION
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.